( e observed amongfemale recipients of ...)Data Published in The Lancet Show Gardasil was 100 Percent,Effective in Preventing High-Grade Vulvar and Vaginal Lesions,Caused by HPV Types 16 and 18,Health

e observed among female recipients of GARDASIL at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients are shown in Table 6. Table 6 Vaccine-related Injection-site and Systemic Adverse Experiences* ---------------------------------------------------------------------- Aluminum-Containing Saline GARDASIL Placebo Placebo Adverse Experience (N = 5088) (N = 3470) (N = 320) (1 to 5 Days Postvaccination) % % % ---------------------------------------------------------------------- Injection Site Pain 83.9 75.4 48.6 Swelling 25.4 15.8 7.3 Erythema 24.6 18.4 12.1 Pruritus 3.1 2.8 0.6 ---------------------------------------------------------------------- GARDASIL Placebo Adverse Experience (N = 5088) (N = 3790) (1 to 15 Days Postvaccination) % % ---------------------------------------------------------------------- Systemic Fever 10.3 8.6 Nausea 4.2 4.1 Dizziness 2.8 2.6 ---------------------------------------------------------------------- * The vaccine-related adverse experiences that were observed among recipients of GARDASIL were at a frequency of at least 1.0% and also at a greater frequency than that observed among placebo recipients. All-cause Common Systemic Adverse Experiences All-cause systemic adverse experiences for female subjects that were observed at a frequency of greater than or equal to 1% where the incidence in
'"/>




Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32
Related medicine technology :

1. New Phase 3 Study Published in The Lancet Evaluates Efficacy and Safety of Prezista/Ritonavir vs. Kaletra as Part of HIV Combination Therapy in Treatment-Experienced Adults With HIV
2. New Proof of Genisteins Efficacy and Safety for Osteopenia and Osteoporosis Published in Annals of Internal Medicine
3. Bio-Matrix Scientifics Dr. ONeill Sees University of Pittsburghs Published Study on Culture Blood-Forming Stem Cells from Human Fat Tissue as Supporting Near Term Benefits of Banking Adipose (Fat) Derived Stem Cells
4. Interim Analysis of Crinone Pregnancy Study to Be Published in American Society for Reproductive Medicine Journal
5. VIVUS Announces Abstract Published at American Diabetes Association Scientific Sessions
6. Anacor Identifies a Novel Mechanism for Its Lead Anti-Fungal Drug, AN2690; Findings Published in Science
7. Research on New Treatment for Neglected Disease Published in The New England Journal of Medicine
8. Landmark Study Published in the New England Journal of Medicine Shows Important Benefits of Eprodisate (KIACTA) Treatment for Patients with Amyloid A (AA) Amyloidosis
9. Newly Published Data from Large Study Support Cardiovascular Safety of Avandia (Rosiglitazone Maleate)
10. Javelin Pharmaceuticals Phase II Rylomine (Intranasal Morphine) Data Published in Pain Medicine
11. Newly Published Data Demonstrates Superiority of Cipralex Over Duloxetine for Acute Treatment of Depression